The company wholesale business through Jiuxin Medicine, distributing third-party pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine (TCM), personal and family care products, and medical devices, as well as convenience products, including consumable, seasonal, and promotional items. It has two segments offline wholesale and online platform. The majority revenue generated from offline wholesale.
We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.
The chart below shows how we grade Ridgetech (RDGT) across the board compared to its closest peers.
Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.
See how Ridgetech compares to its peers in these key performance metrics from Benzinga Rankings.
The two main factors that we consider when analyzing past performance is overall return and volatility
Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.
This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.
Ridgetech (RDGT) sharpe ratio over the past 5 years is -0.0003 which is considered to be above average compared to the peer average of -0.0095
